profile-img
Seb Walsh

@seb_walsh

Public Heath Doctor and NIHR Doctoral Fellow researching population approaches to dementia risk reduction @CamPubHealth. Views own, retweets not endorsements.

calendar_today15-05-2012 12:56:02

5,1K Tweets

864 Followers

922 Following

Seb Walsh(@seb_walsh) 's Twitter Profile Photo

'Neither targeted lecanemab treatment nor treatment unrestricted by APOE ε4 genotype is cost-effective vs SoC alone for patients with MCI or mild dementia due to AD. Lecanemab would be cost-effective in some settings if priced below $5,100 per year.'

neurology.org/doi/abs/10.121…

account_circle